OakChart

Medifast Inc

MEDConsumer Cyclical·Personal Services·USA·Micro·NYSE·Nov 11 • 10:20 AM ET

13.22+0.19 (1.46%)
2026-11-11 16:20 CET
Market cap
145.71 USD m
Revenue, TTM
299.57 USD m
Net income, TTM
-40.85 USD m
Free cash flow, TTM
-3.87 USD m
EPS diluted, TTM
-3.69
P/E
-
Compare

Price

MED against its 20, 50 and 200-day averages
2050200beatmiss
10.0011.0012.0013.00793K1.6MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MEDclose 13.2220-day 12.4450-day 12.12200-day 11.3613.22

3.0% under 13.63 on 9 Nov 2026. Last 15 sessions, 16.8% high to low

Profile

MED
52-week range, 91% of the way up
9.2213.63

Medifast, Inc. is a health and wellness company, which engages in the provision of habit-based and coach-guided lifestyle solutions called OPTAVIA. It offers and ships OPTAVIA products directly to its customers. It focuses on coaching healthy habits through a health transformational system. The company was founded by William Vitale in 1980 and is headquartered in Baltimore, MD.

Employees380
IPODec 30, 1993
Beta0.67
ATR, 14d0.46
Rel volume0.30
Short float12.34%
Insider own6.03%
Inst own73.55%

Snapshot

6 groups

Valuation

Index-
Market Cap147.83M
Enterprise Value-4.02M
Income-40.85M
Sales299.57M
Book/sh16.12
Cash/sh15.43
Dividend Est.-
Dividend TTM-
Dividend Ex-DateSep 18, 2023
Dividend Gr. 3/5Y- -
Payout-
Employees380
IPODec 30, 1993

Ratios

P/E-
Forward P/E-
PEG-
P/S0.49
P/B0.82
P/C0.86
P/FCF-
EV/EBITDA-
EV/Sales-0.01
Quick Ratio4.32
Current Ratio4.82
Debt/Eq0.11
LT Debt/Eq0.10
Option/ShortYes / Yes

Earnings

EPS (ttm)-3.69
EPS next Y-0.04
EPS next Q0.01
EPS this Y-43.33%
EPS next Y95.35%
EPS next 5Y-
EPS past 3/5Y- -
Sales past 3/5Y-37.74% -16.22%
EPS Y/Y TTM-16409.29%
Sales Y/Y TTM-30.28%
EPS Q/Q-661.35%
Sales Q/Q-19.42%
EarningsOct 26 BMO
EPS/Sales Surpr.45.71% 1.05%

Ownership

Insider Own6.03%
Insider Trans19.94%
Inst Own73.55%
Inst Trans-9.71%
ROA-16.08%
ROE-20.69%
ROIC-20.64%
Gross Margin69.76%
Oper. Margin-5.73%
Profit Margin-13.64%
SMA206.23%
SMA509.08%
SMA20016.34%
Trades-

Technical

Shs Outstand11.18M
Shs Float10.51M
Short Float12.34%
Short Ratio10.61
Short Interest1.30M
52W High13.63 -3.01%
52W Low9.22 43.38%
Volatility4.18% 3.90%
ATR (14)0.46
RSI (14)63.45
Beta0.67
Rel Volume0.30
Avg Volume122.23K
Volume6,243

Performance

Perf Week0.53%
Perf Month13.28%
Perf Quarter15.16%
Perf Half Y5.93%
Perf YTD23.78%
Perf Year13.48%
Perf 3Y-79.79%
Perf 5Y-94.21%
Perf 10Y-65.91%
Recom3.00
Target Price12.00
Prev Close13.03
Price13.22
Change %1.46%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 05, 2024UpgradeDDA DavidsonUnderperform → Neutral$16.50 → $17+28.6%
Jun 05, 2024DowngradeDDA DavidsonNeutral → Underperform$25 → $17.50+32.4%
Oct 13, 2023InitiatedSStephensEqual-Weight$82+520.3%
Nov 04, 2022DowngradeDDA DavidsonBuy → Neutral$278 → $106+701.8%
Aug 04, 2022DowngradeJJefferiesBuy → Hold$345 → $150+1,034.6%
Jan 25, 2021UpgradeJJefferiesHold → Buy$205 → $265+1,904.5%
Nov 05, 2020UpgradeDDA DavidsonNeutral → Buy$180 → $205+1,450.7%
Jun 25, 2020InitiatedBB. Riley FBRBuy$164+1,140.5%
Feb 27, 2020DowngradeJJefferiesBuy → Hold$130 → $90+580.8%
Nov 08, 2019DowngradeDDougherty & CompanyBuy → Neutral

Peers

Mkt cap
TickerCompanyMkt cap
WWWW International Inc129.70M
HLFHerbalife Ltd1.62B
NATRNature's Sunshine Products Inc183.94M
USNAUsana Health Sciences Inc240.18M
LFMDLifeMD Inc83.15M
HIMSHims & Hers Health Inc4.58B
NUSNu Skin Enterprises Inc194.64M
LFVNLifevantage Corp62.65M
SMPLSimply Good Foods Co1.06B
BRBRBellring Brands Inc1.17B

Insider trading

13 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Kiai ParsaDirectorNov 04 '26Buy13.036618,61021,089Nov 06 02:28 PM
Kiai ParsaDirectorOct 28 '26Buy12.245,55768,027712,891Oct 30 12:56 PM
Chard Daniel RDirectorSep 28 '26Sale11.989,545114,338140,153Sep 30 08:04 PM
Chard Daniel RDirectorSep 29 '26Sale11.739,544111,951130,609Sep 30 08:04 PM
Chard Daniel ROfficerSep 29 '26Proposed Sale11.739,544111,951Sep 29 03:24 PM
Chard Daniel ROfficerSep 28 '26Proposed Sale11.989,545114,338Sep 28 12:26 PM
Kiai ParsaDirectorAug 26 '26Buy12.2643,150529,157707,492Aug 28 12:47 PM
Kiai ParsaDirectorAug 24 '26Buy12.004,32951,946665,517Aug 26 11:47 AM
Kiai ParsaDirectorAug 20 '26Buy11.6043,150500,700661,306Aug 21 12:35 PM
Kiai ParsaDirectorAug 19 '26Buy11.6629,337341,999619,331Aug 21 12:35 PM
SCHLACKMAN SCOTTDirectorMay 08 '26Buy12.652,50031,62528,049May 12 07:10 PM
SCHLACKMAN SCOTTDirectorMay 11 '26Buy12.532,50031,32530,549May 12 07:10 PM
Chard Daniel RChairman & CEOMar 20 '26Buy10.1117,678178,72517,678Mar 27 05:51 PM

Held by

AUM
TickerCompanyAUM
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
DFSVUS Small Cap Value Portfolio ETF Class Shares-
FNDASchwab Fundamental U.S. Small Company ETFAUM: 8.98B
SMLFiShares U.S. Small-Cap Equity Factor ETFAUM: 4.26B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFASU.S. Small Cap Portfolio-ETF Class Shares-
BSVOEA Bridgeway Omni Small-Cap Value ETFAUM: 2.44B
FSCCFederated Hermes MDT Small Cap Core ETFAUM: 457.96M
IWCiShares Micro-Cap ETFAUM: 1.22B

News

latest 14 of 206
  • Medifast Beats And Guides To A Fourth-Quarter Profit, But Cost Cuts Are Doing The Work While Coaches And Revenue Keep Shrinking (Earnings Whispers)
  • Medifast: Q3 Earnings Snapshot (Associated Press)
  • Medifast Announces Third Quarter 2026 Financial Results (Business Wire)
  • Why Is Weight Loss Different During Menopause? Common Myths Debunked (GlobeNewswire)
  • Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2026 (Business Wire)
  • Loading…
  • 5 Questions People Ask When Every Weight Loss Approach Has Failed (GlobeNewswire)
  • What Actually Keeps Weight Off After a Weight Loss Program (GlobeNewswire)
  • Why Do You Keep Gaining Weight Back After Losing It (GlobeNewswire)
  • What Are the 5 Signs of Poor Metabolic Health Adults May Overlook? (GlobeNewswire)
  • Why Weight Loss Plateaus Happen: 5 Metabolic Causes (GlobeNewswire)
  • Ocius Technology to Add Sonar Systems to Bluebottle Fleet: NYSE Content Update (PR Newswire)
  • Medifast Announces the Launch of the Medifast Metabolic Health Institute (Business Wire)
  • Medifast Inc (MED) (Q2 2026) Earnings Call Highlights: Strategic Pivot to Trilivy and ... (GuruFocus.com) +34.29%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-26-0.190-0.350-1.57072.0571.301
2026Q22026-08-03-0.280-0.650-0.27876.3872.701
2026Q12026-05-04-0.190-0.520-0.19376.0469.201
2025Q42026-02-17-0.550-0.820-1.64975.1071.401
2025Q32025-11-03-0.210-0.360-0.20689.4189.701
2025Q22025-08-040.401-0.1900.224105.56101.81
2025Q12025-04-28-0.034-0.250-0.071115.73116.41
2024Q42025-02-180.100-0.1500.073119118.052
2024Q32024-11-040.350-0.1900.103140.16138.152
2024Q22024-08-050.9200.389-0.746168.56174.052
2024Q12024-04-290.6600.8020.759174.74173.452
2023Q42024-02-201.0900.9620.552191.02184.172
2023Q32023-11-062.1201.0652.116235.87232.12
2023Q22023-08-072.7701.4402.774296.19270.21
2023Q12023-05-013.6702.4003.667348.98319.521
2022Q42023-02-213.7002.2162.412337.25330.071

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2016FY1.8901.8801.490274.53277.09
2017FY2.2902.1702.290301.56297.06
2018FY4.6204.5174.619501498.03
2019FY5.9605.8406.430713.67704.7
2020FY9.1409.2388.680934.84919.16
2021FY13.89013.63313.8861,5261,524
2022FY14.50013.04612.7321,5991,591
2023FY9.6409.5189.1031,0721,065
2024FY1.8401.7800.191602.46601.55
2025FY-0.600-1.120-1.700385.79382.1
2026FY--0.860--288.5
2027FY--0.040--274.5

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-2610064.1064.1064.10
2026Q4S2026-10-1810064.1064.1064.10
2026Q4S2026-08-0411064.1064.1064.10
2026Q4S2026-07-1910063.2063.2063.20
2026Q4S2026-05-0511063.2063.2063.20
2026Q4S2026-05-0410062.0062.0062.00
2026Q4S2026-02-1810162.0062.0062.00
2026Q4S2026-01-1910073.9073.9073.90
2026Q4S2025-11-1110173.9073.9073.90
2026Q4S2025-11-1010173.9073.9073.90
2026Q4S2025-11-0910173.9073.9073.90
2026Q4S2025-11-0810173.9073.9073.90
2026Q4S2025-11-0710173.9073.9073.90
2026Q4S2025-11-0610173.9073.9073.90

Estimate history

EPS, annual2.294.6196.438.6813.88612.7329.1030.191-1.7-3.6859
Period201720182019202020212022202320242025TTM
EPS, quarterly0.1030.073-0.0710.224-0.206-1.649-0.193-0.278-1.566
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual301.563501.003713.672934.8421526.0871598.5771072.054602.463385.788299.57
Period201720182019202020212022202320242025TTM
Sales, quarterly140.163119.003115.728105.55589.40975.09676.04476.38472.048
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual11.97111.86811.76411.77211.59310.87310.89610.93810.99111.183
Period201720182019202020212022202320242025MRQ
Shares, quarterly10.93710.93810.99110.99110.99110.99111.11911.18111.183
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue299.57385.79602.461,072.051,598.581,526.09934.84713.67501.00
Cost of Goods Sold Incl. D&A90.60110.60157.84296.20445.96398.49237.03176.81121.10
Gross Profit208.97275.19444.62775.851,152.611,127.60697.82536.86379.90
Selling, General and Administrative Excl. Other226.15289.40441.75649.45936.61911.36563.66445.82310.84
Research and Development6.004.304.604.604.504.402.802.702.20
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-17.18-14.212.88126.40216.01216.24134.1691.0469.06
Interest Expense0.000.000.000.000.700.230.000.000.00
Unusual Expense18.61-0.024.090.0031.200.000.00--
Net Income Before Taxes-29.15-5.643.79128.80184.06216.13134.2692.3670.55
Income Taxes11.7013.031.7029.3840.4952.1031.4114.4514.76
Consolidated Net Income-40.85-18.672.0999.42143.57164.03102.8677.9255.79
Net Income From Continuing Operations-40.85-18.672.0999.42143.57164.03102.8677.9255.79
Net Income-40.85-18.672.0999.42143.57164.03102.8677.9255.79
EPS (Recurring)-2.49-1.700.459.1014.6713.898.686.434.62
EPS (Basic, Before Extraordinaries)-3.69-1.700.199.1312.8214.018.746.624.67
EPS (Diluted)-3.69-1.700.199.1012.7313.898.686.434.62
EBITDA-4.42-3.7120.28144.12233.08228.12141.4395.6673.50
Non-Operating Income (Expense)6.648.565.002.40-0.050.120.111.321.49
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense6.116.035.826.478.737.234.963.302.47
Price To Earnings Ratio--26.376.138.7415.0822.6117.0527.11
Price To Sales Ratio0.430.300.320.680.811.622.491.863.01
Gross Margin69.7671.3373.8072.3772.1073.8974.6575.2275.83
Operating Margin-5.73-3.680.4811.7913.5114.1714.3512.7613.78
Net Margin-13.64-4.840.359.278.9810.7511.0010.9211.14
Shares Outstanding11.1810.9910.9410.9010.8711.5911.7711.7611.87
Market Capitalization145.71145.71192.72732.201,260.432,432.782,310.881,272.821,483.74

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue72.0576.3876.0475.1089.41105.56115.73119.00
Cost of Goods Sold Incl. D&A20.3722.9924.2922.9627.2528.9131.4830.78
Gross Profit51.6853.4051.7652.1462.1676.6484.2588.22
Selling, General and Administrative Excl. Other55.6357.7252.8559.9466.2477.7185.5187.51
Research and Development2.801.101.101.001.101.101.001.30
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-3.95-4.33-1.09-7.80-4.08-1.07-1.260.71
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense15.410.000.003.210.00-2.62-0.600.35
Net Income Before Taxes-17.84-2.99-1.94-6.38-2.662.880.531.27
Income Taxes-0.320.110.1811.74-0.400.401.300.47
Consolidated Net Income-17.51-3.10-2.12-18.12-2.262.48-0.770.80
Net Income From Continuing Operations-17.51-3.10-2.12-18.12-2.262.48-0.770.80
Net Income-17.51-3.10-2.12-18.12-2.262.48-0.770.80
EPS (Recurring)-0.60-0.28-0.19-1.44-0.210.06-0.110.10
EPS (Basic, Before Extraordinaries)-1.57-0.28-0.19-1.65-0.210.23-0.070.07
EPS (Diluted)-1.57-0.28-0.19-1.65-0.210.22-0.070.07
EBITDA-1.59-0.882.39-4.34-0.632.982.028.59
Non-Operating Income (Expense)1.521.34-0.854.631.421.321.190.92
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.461.441.501.720.722.631.521.68
Price To Earnings Ratio---511.0041.47-71.2526.37
Price To Sales Ratio0.430.370.320.300.350.320.270.32
Gross Margin71.7369.9068.0669.4369.5272.6172.8074.13
Operating Margin-5.49-5.66-1.44-10.39-4.56-1.01-1.090.60
Net Margin-24.30-4.06-2.79-24.13-2.532.35-0.670.67
Shares Outstanding11.1811.1811.1210.9910.9910.9910.9910.94
Market Capitalization145.71117.97112.00117.39150.25154.42147.44192.72

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments167.27162.34150.0487.69109.54174.4792.68101.0398.83
Short Term Receivables0.000.000.000.000.000.581.441.010.58
Inventories20.2342.4254.59118.86180.0453.3948.7738.8919.33
Other Current Assets14.189.6419.4016.2417.285.8611.274.596.46
Total Current Assets201.68214.40224.03222.78306.87234.31154.15145.52125.20
Net Property, Plant & Equipment38.4648.6867.1175.6480.5938.1438.8419.7518.61
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Deferred Tax Assets9.0420.4820.4621.8918.548.455.724.95-
Other Assets7.839.6714.6512.466.472.940.351.182.12
Total Assets257.01293.23326.25332.78412.46283.84199.06171.40145.93
Short Term Debt Incl. Current Port. of LT Debt4.606.185.885.786.523.673.170.000.00
Accounts Payable15.0723.0539.1958.6770.8935.7722.6121.8116.15
Income Tax Payable0.291.841.092.002.572.981.551.070.60
Other Current Liabilities23.0133.0846.1374.4589.8468.9352.0637.4420.40
Total Current Liabilities42.9664.1692.30140.89169.83111.3579.3960.3237.14
Long Term Debt6.099.9416.1320.2726.027.4910.430.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities9.049.0216.3416.5714.137.764.411.970.21
Other Liabilities0.000.000.000.000.000.000.000.000.00
Total Liabilities58.0983.12124.77177.74209.98126.6094.2362.3037.35
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity198.92210.11201.48155.04202.47157.25104.83109.11108.58
Total Shareholders Equity198.92210.11201.48155.04202.47157.25104.83109.11108.58
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity198.92210.11201.48155.04202.47157.25104.83109.11108.58
Total Liabilities & Stockholders Equity257.01293.23326.25332.78412.46283.84199.06171.40145.93
Book Value Per Share18.1019.2118.4914.2617.4713.368.919.199.07
Tangible Book Value Per Share18.1019.2118.4914.2617.4713.368.919.199.07
Full-Time Employees380504634874984713550420399
Price to Book Ratio0.810.933.798.3711.9914.7012.3013.607.70
Return on Assets-6.790.6830.1738.5347.1242.6042.0635.1620.75
Return on Equity-9.131.0255.7780.3191.2078.4972.8451.2627.10
Return on Invested Capital-9.110.9545.6981.8971.7962.4467.6051.1325.53
Quick Ratio4.222.681.840.740.751.621.331.772.85
Current Ratio4.693.342.431.581.812.101.942.413.37

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-40.85-18.672.0999.42143.57164.03102.8677.9255.79
Depreciation12.7614.2412.7117.7117.0811.887.274.624.43
Other Funds (Non Cash)21.189.6426.839.0413.209.997.888.633.75
Funds from Operations5.2016.6734.22127.38172.92182.19118.6192.7761.28
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-5.22-9.80-9.7420.2821.65-87.6526.58-8.51-0.47
Income Taxes Payable0.21-6.6010.21-9.151.37----
Cash from Operating Activities-0.036.8624.48147.66194.5794.55145.2084.2660.82
Capital Expenditures-3.84-5.61-7.45-6.48-16.68-34.21-5.89-10.06-4.94
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses3.640.000.000.000.000.000.000.000.20
Purchase or Sale of Investments-39.93-2.31-19.07-54.565.275.144.613.733.54
Purchase of Investments-183.96-84.41-46.59-54.560.000.000.000.000.00
Sale Or Maturity of Investments144.0382.0927.530.005.275.144.613.733.54
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-40.14-7.93-26.52-61.05-11.41-29.06-1.28-6.33-1.20
Cash Dividends Paid-0.17-0.20-0.71-73.02-71.62-63.86-53.19-35.40-23.16
Change in Capital Stock-0.82-0.37-0.80-6.77-127.96-61.28-3.95-46.93-30.17
Repurchase of Common Pref Stock-0.82-0.37-0.84-6.96-127.96-62.09-5.55-47.21-30.71
Sale of Common Pref Stock0.000.000.040.190.000.811.600.280.55
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities-0.99-0.56-1.51-79.79-199.58-125.13-57.14-82.32-53.33
Exchange Rate Effect-0.000.05-0.07-0.070.11-0.020.00-0.00
Net Change in Cash-41.15-1.62-3.516.75-16.49-59.5486.75-4.396.29
Free Cash Flow-3.871.2517.02141.17177.8960.34139.3174.2055.88
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow-111.2711.8510.7712.24-27.0234.2146.16
Deferred Taxes & Investment Tax Credit-11.46-7.401.21-0.92-3.710.601.60-2.69

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments172.53169.82168.95167.27173.51162.67
Short Term Receivables0.000.000.000.000.000.00
Inventories21.2021.1821.4020.2323.2030.20
Other Current Assets8.2011.0312.2814.1811.1213.57
Total Current Assets201.94202.03202.63201.68207.84206.44
Net Property, Plant & Equipment32.7452.2942.5638.4641.2443.45
Total Investments and Advances0.000.000.000.000.000.00
Deferred Tax Assets---9.0412.1111.46
Other Assets5.086.076.857.837.027.98
Total Assets239.76260.40252.05257.01268.21269.33
Short Term Debt Incl. Current Port. of LT Debt3.085.163.924.605.475.92
Accounts Payable38.8036.4138.2638.3641.2440.26
Income Tax Payable---0.000.000.00
Other Current Liabilities-0.000.00-0.000.000.00-0.00
Total Current Liabilities41.8841.5642.1842.9646.7146.18
Long Term Debt17.6122.4612.186.096.797.14
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---9.04--
Other Liabilities0.000.000.000.000.000.00
Total Liabilities59.4964.0254.3758.0953.5053.33
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity180.28196.38197.68198.92214.71216.00
Total Shareholders Equity180.28196.38197.68198.92214.71216.00
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity180.28196.38197.68198.92214.71216.00
Total Liabilities & Stockholders Equity239.76260.40252.05257.01268.21269.33
Book Value Per Share16.1217.5617.7818.1019.5319.65
Tangible Book Value Per Share16.1217.5617.7818.1019.5319.65
Full-Time Employees---380--
Price to Book Ratio0.810.600.560.550.700.73
Return on Assets-16.08-9.67-7.53-6.790.091.29
Return on Equity-20.69-12.42-9.80-9.130.121.73
Return on Invested Capital-8.85-1.42-1.01-8.84-1.021.11
Quick Ratio4.324.354.304.223.953.82
Current Ratio4.824.864.804.694.454.47

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-17.51-3.10-2.12-18.12-2.262.48
Depreciation2.363.453.483.463.454.04
Other Funds (Non Cash)14.012.820.813.542.500.94
Funds from Operations-1.143.172.171.003.057.45
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital4.43-1.47-1.91-6.289.06-10.83
Income Taxes Payable1.170.06-0.20-0.820.21-7.14
Cash from Operating Activities3.291.700.26-5.2812.11-3.38
Capital Expenditures-0.43-0.97-1.10-1.35-1.36-1.38
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.003.640.000.000.00
Purchase or Sale of Investments-16.39-0.26-19.67-3.60-12.9214.73
Purchase of Investments-56.27-45.46-49.32-32.91-20.43-16.07
Sale Or Maturity of Investments39.8745.2029.6529.317.5130.81
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-16.82-1.23-17.13-4.95-14.2813.36
Cash Dividends Paid0.00-0.08-0.090.000.00-0.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-0.010.00-0.810.000.00-0.00
Repurchase of Common Pref Stock-0.010.00-0.810.000.00-0.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-0.01-0.08-0.900.000.00-0.00
Exchange Rate Effect---0.000.000.00
Net Change in Cash-13.540.38-17.77-10.22-2.179.98
Free Cash Flow2.870.73-0.84-6.6310.75-4.76
Price to Free Cash Flow-30.74-111.37333.14-

Revenue breakdown

Miscellaneous Food Preparations & Kindred Products2024: 602.46M 2025: 385.79M
United States2024: 602.46M 2025: 385.79M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3012.34%1.3M10.5M143.10K
2026-10-1511.01%1.2M10.5M144.78K
2026-09-3010.02%1.1M10.5M156.74K
2026-09-1517.75%1.9M10.5M201.20K
2026-08-3117.97%1.9M10.5M207.68K
2026-08-1417.41%1.8M10.5M221.97K
2026-07-3114.16%1.5M10.5M221.71K
2026-07-1515.72%1.6M10.4M221.26K
2026-06-3014.97%1.6M10.4M229.76K
2026-06-1520.67%2.2M10.4M213.71K
2026-05-2920.88%2.2M10.4M235.95K
2026-05-1520.79%2.2M10.5M251.95K
2026-04-3019.30%2.0M10.5M248.55K
2026-04-1520.71%2.2M10.5M258.54K
2026-03-3119.34%2.1M10.6M262.80K
2026-03-1319.16%2.0M10.6M265.49K
2026-02-2719.02%2.0M10.6M261.34K
2026-02-1319.58%2.1M10.6M246.65K
2026-01-3018.88%2.0M10.6M242.40K
2026-01-1520.32%2.2M10.6M236.53K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.509.9011.400.0011.2230.000.000.990-0.0160.001
call5.007.509.005.396.9642.000.000.983-0.0160.001
call7.505.106.502.324.5359.000.000.972-0.0150.001
call10.002.953.303.661.6935,4360.000.951-0.0140.002
call12.500.600.900.770.6917730.000.724-0.0240.007
call15.000.000.050.050.6065750.000.087-0.0110.003
call17.500.000.050.051.0655.000.000.055-0.0130.002
call20.000.000.350.501.45517.000.000.044-0.0150.002
call22.500.000.750.051.77010.000.000.038-0.0170.002
call25.000.000.700.002.0400.000.000.033-0.0170.002
put2.500.000.050.055.2893.000.00-0.010-0.0150.001
put5.000.000.750.003.2950.000.00-0.017-0.0160.001
put7.500.000.750.102.02928.000.00-0.028-0.0150.001
put10.000.000.050.051.1261060.00-0.048-0.0130.002
put12.500.050.200.170.5671,2700.00-0.276-0.0220.007
put15.001.502.253.451.2433.000.00-0.910-0.0100.003
put17.503.804.900.002.1440.000.00-0.944-0.0120.002
put20.006.107.600.002.9850.000.00-0.956-0.0130.002
put22.508.6010.100.003.4330.000.00-0.962-0.0140.002
put25.0010.6013.000.004.3200.000.00-0.967-0.0150.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-10-304Statement of changes in beneficial ownership of securities2026-10-28SEC
2026-10-2610-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-268-KCurrent report2026-10-26SEC
2026-09-304Statement of changes in beneficial ownership of securities2026-09-28SEC
2026-09-29144Filing for proposed sale of securities under Rule 144.SEC
2026-09-28144Filing for proposed sale of securities under Rule 144.SEC
2026-08-284Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-264Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-21SCHEDULE 13D/ASEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-19SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-12SCHEDULE 13G/ASEC
2026-08-03S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-08-0310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-038-KCurrent report2026-08-03SEC
2026-07-29SCHEDULE 13G/ASEC
2026-07-178-KCurrent report2026-07-17SEC
2026-07-103/A2026-05-19SEC
2026-06-018-KCurrent report2026-05-29SEC
2026-05-284Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-284Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-284Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-284Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-284Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-284Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-283Initial statement of beneficial ownership of securities2026-05-19SEC
2026-05-283Initial statement of beneficial ownership of securities2026-05-19SEC
2026-05-268-KCurrent report2026-05-19SEC
2026-05-15SCHEDULE 13GSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-118.61K100
2026-1068.03K100
2026-0900226.29K2
2026-081.42M400
2026-070000
2026-060000
2026-0562.95K200
2026-040000
2026-03178.72K100
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
RENAISSANCE TECHNOLOGIES LLC7.00%
Steamboat Capital Partners, LLC6.36%
TWO SIGMA INVESTMENTS, LP4.33%
VANGUARD CAPITAL MANAGEMENT LLC4.02%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC3.57%
DIMENSIONAL FUND ADVISORS LP3.34%
BlackRock, Inc.3.32%
AMERICAN CENTURY COMPANIES INC2.87%
MORGAN STANLEY2.63%
GOLDMAN SACHS GROUP INC2.19%

Funds

Fund% owned
Avantis U.S. Small Cap Value ETF3.20%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.87%
Schwab Fundamental U.S. Small Company ETF2.35%
VANGUARD CONSUMER STAPLES INDEX FUND1.18%
iShares U.S. Small-Cap Equity Factor ETF1.09%
VANGUARD EXTENDED MARKET INDEX FUND1.04%
U.S. SMALL CAP VALUE PORTFOLIO1.00%
Fidelity Small Cap Index Fund0.94%
Schwab Fundamental U.S. Small Company Index Fund0.61%
Dimensional US Small Cap Value ETF0.55%

OakChart. MED. Cached 15 minutes.